Future Perspective: Key Factors Influencing the Concussion Market Until 2029

The concussion market is poised for steady growth as awareness and management of brain injuries continue to improve worldwide. Advancements in technology, increased collaboration between medical and sports sectors, and expanding research efforts are all contributing to the market's positive outlook. Let's explore the market's size projections, key players, emerging trends, and segmentation to understand the dynamics shaping this industry.

Projected Growth Trajectory of the Concussion Market Size Until 2029
The concussion market is forecasted to expand steadily, reaching $9.9 billion by 2029 at a compound annual growth rate (CAGR) of 4.8%. This upward trend is driven by ongoing emphasis on sports safety measures, continuous R&D in treatment options, wider adoption of concussion management protocols, rising public health awareness, and stronger cooperation between healthcare providers and sports organizations. Important trends influencing the market include teleconcussion services and remote patient monitoring, educational programs aimed at preventing concussions, studies into long-term consequences such as chronic traumatic encephalopathy (CTE), enforcement of concussion guidelines in sports, development of neuroprotective drugs, and new legislation focused on concussion care.

Download a free sample of the concussion market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11888&type=smp

Key Players Dominating the Concussion Market Landscape
Leading companies actively involved in the concussion market include Pfizer Inc., Novartis AG, Sanofi SA, Abbott Laboratories, Medtronic plc, Viatris Inc., Zydus Lifesciences Ltd., Integra LifeSciences Corporation, Nihon Kohden Corporation, Raumedic AG, Lupin Limited, NeuroPace Inc., Compumedics Limited, NeuroLogica Corporation, Neural Analytics Inc., NovaSignal Corp., Back Bay Life Science Advisors, BrainScope Company Inc., Neuro Kinetics Inc., ImPACT Applications Inc., NanoDx Inc., Neuren Pharmaceuticals Limited, Advanced Brain Monitoring Inc., ElMindA Ltd., NeurOptics Inc., InfraScan Inc., Neuro Assessment Systems Inc., NeuroTrauma Sciences LLC, SyncThink Inc., Oxeia Biopharmaceuticals Inc., Oculogica Inc., Banyan Biomarkers Inc., Emotiv Inc., BioDirection Inc., and Neurologic Wellness Institute.

Strategic Acquisition Highlighting Innovation in Concussion Treatment
In August 2023, Oxeia Biopharmaceuticals Inc., a clinical-stage biotechnology firm based in the United States, acquired SUN11031-a synthetic human ghrelin-from Kinemed Inc. Although the financial details weren't disclosed, this acquisition is expected to lead toward the development of SUN11031 as OXE103 for treating concussions and other acute neurotrauma cases. Kinemed Inc. is also a research and development company located in the US, specializing in pharmaceutical innovations.

View the full concussion market report:
https://www.thebusinessresearchcompany.com/report/concussion-global-market-report

Emerging Trends Accelerating Growth in the Concussion Market
One of the prominent trends shaping the concussion market is product innovation, as companies strive to improve diagnostic and treatment capabilities to maintain a competitive edge. For example, in May 2022, TecTraum Inc., a US-based medical device developer, collaborated with Nottingham-Spirk Design Associates Inc., a product design firm, to create pro2cool. This device represents the world's first point-of-care treatment designed specifically for concussions. It is a noninvasive hypothermic system aimed at reducing concussion symptom severity and helping patients recover more quickly to their pre-injury condition by locally cooling the head and neck to lower blood temperature before it reaches the brain. Previous clinical research has demonstrated that brain cooling within days after a concussion significantly enhances clinical outcomes.

Market Segmentation Breakdown for the Concussion Industry
The concussion market is segmented into the following categories:
1) Assessment: Diagnosis and Treatment
2) Device: Imaging Devices, Magnetic Resonance Imaging (MRI) Devices, X-Ray Equipment, Computed Tomography (CT) Devices, Monitoring Devices, and Other Devices
3) End User: Hospitals and Clinics, Diagnostic Centers, Medical Camps, and Other End Users

Further subsegments include:
- Diagnosis: Clinical Assessments and Imaging Techniques
- Treatment: Pharmacological Therapies, Cognitive Rehabilitation, and Physical Therapy

This detailed segmentation helps in understanding the various facets of concussion care and the diverse technologies and services driving the market forward.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.